Clinical Operations, • 9/19/25 Beyond the Feasibility Survey: Strategic Site Selection to Accelerate Trials and Optimize Resources Previous Optimizing CRO and Vendor Selection - Examples from the Field Next Purpose-Driven Metrics: Running Gene Therapy Trials with KPIs That Matter You Might Also Like Solutions for Trial Design Challenges in Rare Disease Trials What Matters to Payers: Conversations You Should Start During Phase 2 Purpose-Driven Metrics: Running Gene Therapy Trials with KPIs That Matter Reducing Patient Burden in Rare Disease Trials Accelerating Rare Disease Therapies: Strategies for Efficient Clinical Development
Clinical Operations, • 9/19/25 Beyond the Feasibility Survey: Strategic Site Selection to Accelerate Trials and Optimize Resources Previous Optimizing CRO and Vendor Selection - Examples from the Field Next Purpose-Driven Metrics: Running Gene Therapy Trials with KPIs That Matter You Might Also Like Solutions for Trial Design Challenges in Rare Disease Trials What Matters to Payers: Conversations You Should Start During Phase 2 Purpose-Driven Metrics: Running Gene Therapy Trials with KPIs That Matter Reducing Patient Burden in Rare Disease Trials Accelerating Rare Disease Therapies: Strategies for Efficient Clinical Development
